0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Academia and the Profession |

Diagnosis and Management of Adults with Pharyngitis: A Cost-Effectiveness Analysis

Joan M. Neuner, MD, MPH; Mary Beth Hamel, MD, MPH; Russell S. Phillips, MD; Kira Bona, BS; and Mark D. Aronson, MD
[+] Article and Author Information

From Medical College of Wisconsin, Milwaukee, Wisconsin, and Beth Israel Deaconess Medical Center, Boston, Massachusetts.


Presented in part at the annual meeting of the Society of General Internal Medicine, San Diego, California, May 2001.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Mark D. Aronson, MD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rose Building, Room 118, Boston, MA 02215.

Current Author Addresses: Dr. Neuner: Center for Patient Care and Outcomes Research, Medical College of Wisconsin, HRC H2755, 8701 Watertown Plank Road, Milwaukee, WI 53226.

Drs. Hamel, Phillips, and Aronson and Ms. Bona: Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rose Building, Room 118, Boston, MA 02215.


Ann Intern Med. 2003;139(2):113-122. doi:10.7326/0003-4819-139-2-200307150-00011
Text Size: A A A

Background: Rheumatic fever has become uncommon in the United States while rapid diagnostic test technology for streptococcal antigens has improved. However, little is known about the effectiveness or cost-effectiveness of various strategies for managing pharyngitis caused by group A -hemolytic streptococcus (GAS) in U.S. adults.

Objective: To examine the cost-effectiveness of several diagnostic and management strategies for patients with suspected GAS pharyngitis.

Design: Cost-effectiveness analysis.

Data Sources: Published literature, including systematic reviews where possible. When costs were not available in the literature, we estimated them from our institution and Medicare charges.

Target Population: Adults in the general U.S. population.

Time Horizon: 1 year.

Perspective: Societal.

Interventions: Five strategies for the management of adult patients with pharyngitis: 1) observation without testing or treatment, 2) empirical treatment with penicillin, 3) throat culture using a two-plate selective culture technique, 4) optical immunoassay [OIA] followed by culture to confirm negative OIA test results, or 5) OIA alone.

Outcome Measures: Cost per lost quality-adjusted life-days (converted to life-years where appropriate) and incremental cost-effectiveness.

Results of Base-Case Analysis: Empirical treatment was the least effective strategy at a GAS pharyngitis prevalence of 10% (resulting in 0.41 lost quality-adjusted life-day). Although the other four strategies had similar effectiveness (all resulted in about 0.27 lost quality-adjusted life-day), culture was the least expensive strategy.

Results of Sensitivity Analyses: Results were sensitive to the prevalence of GAS pharyngitis: OIA followed by culture was most effective when GAS pharyngitis prevalence was greater than 20%. Observation was least expensive when prevalence was less than 6%, and empirical treatment was least expensive when prevalence was greater than 71%. The effectiveness of strategies was also very sensitive to the probability of anaphylaxis: When the probability of anaphylaxis was about half the baseline probability, OIA/culture was most effective; when the probability was 1.6 times that of baseline, observation was most effective. Only at an OIA cost less than half of baseline did the OIA alone strategy become less expensive than culture. Results were not sensitive to other variations in probabilities or costs of diagnosis or treatment of GAS pharyngitis.

Conclusions: Observation, culture, and two rapid antigen test strategies for diagnostic testing and treatment of suspected GAS pharyngitis in adults have very similar effectiveness and costs, although culture is the least expensive and most effective strategy when the GAS pharyngitis prevalence is 10%. Empirical treatment was not the most effective or least expensive strategy at any prevalence of GAS pharyngitis in adults, although it may be reasonable for individual patients at very high risk for GAS pharyngitis as assessed by a clinical decision rule.

Figures

Grahic Jump Location
Appendix (Figure 1). The tree represents the possible outcomes of an adult with group A β-hemolytic streptococcal ( ) pharyngitis. The node on the left represents a choice among five alternative strategies. All other nodes are chance nodes ( ) or terminal nodes ( ) representing events that might occur (with a certain probability estimated as described in the text) after each strategy is chosen. For example, a patient with pharyngitis could receive penicillin without any testing ( ). That patient would then either have GAS pharyngitis ( ) or non-GAS pharyngitis ( ). If the patient had GAS pharyngitis, he or she could have only symptoms or also have complications shown in the subsequent branches: anaphylaxis, rash, peritonsillar abscess, acute rheumatic fever ( ), or none of these. If the patient did not have GAS pharyngitis, then he or she would still be subject to the risk for anaphylaxis or rash from penicillin given, but no other sequelae. For all other branches that end in a circle, the complete tree is not shown; the complete tree shown for empirical therapy would be followed by using the appropriate branch (labeled either GAS or non-GAS). Note that the tree also shows the consequences of false-positive results on optical immunoassay ( ) antigen tests. For example, a patient with pharyngitis could undergo OIA alone ( ). If that test result were positive, the patient could have GAS pharyngitis (that is, have a true-positive result) and thus might develop the sequelae of pharyngitis; the other possibility is that the patient has a false-positive result and thus faces only the risks of treatment as shown in the empirical therapy branches.
The decision model.GAScirclestrianglesbranch 2upper branchlower branchARFOIAbottom branch
Grahic Jump Location
Grahic Jump Location
Appendix (Figure 2). Adapted from Ebell et al. . Copyright 2000, American Medical Association.
Centor clinical prediction rule for the diagnosis of group A β-hemolytic streptococcal (GAS) pharyngitis in adults.(47)
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)